GREPore-seq: A Robust Workflow to Detect Changes After Gene Editing Through Long-range PCR and Nanopore Sequencing.

Zi-Jun Quan1, Si-Ang Li1, Zhi-Xue Yang1

  • 1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.

Summary

We developed GREPore-seq, a novel pipeline for analyzing CRISPR/Cas9 gene editing outcomes. This method efficiently detects large insertions and deletions, improving clinical therapy development.